Recorded Chinese product: 注射用亚叶酸钙注射用亚叶酸钙

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

亚叶酸钙 其辅料为枸橼酸钠是一种在国家药监局注册认定的药品。该药品含有亚叶酸钙、亚叶酸钙 其辅料为枸橼酸钠、其辅料为枸橼酸钠-76c38f2e等成分。

该药品关联的活性成分包括:亚叶酸钙Yaye Suangai、亚叶酸钙 其辅料为枸橼酸钠、其辅料为枸橼酸钠。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:江苏奥赛康药业股份有限公司Chinese legal name: 江苏奥赛康药业股份有限公司。

您可以探索含有相同成分的其他药品:亚叶酸钙-8f402481成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 注射用亚叶酸钙) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 亚叶酸钙Yaye Suangai.

Manufacturers recorded for this product: 江苏奥赛康药业股份有限公司Chinese legal name: 江苏奥赛康药业股份有限公司.

Explore other medicines containing the same ingredient: 亚叶酸钙 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 注射用亚叶酸钙Recorded Chinese product: 注射用亚叶酸钙
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 300mg300 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 江苏奥赛康药业股份有限公司Chinese legal name: 江苏奥赛康药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20060199

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20060199

Manufacturer

Chinese legal name: 江苏奥赛康药业股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20060199

生产企业

江苏奥赛康药业股份有限公司(国产)

适应症

主要用作叶酸拮抗剂(如甲氨蝶呤、乙胺嘧啶或甲氧苄啶等)的解毒剂。本品临床常用于预防甲氨蝶呤过量或大剂量治疗后所引起的严重毒性作用。当口服叶酸疗效不佳时,也用于口炎性腹泻、营养不良、妊娠期或婴儿期引起的巨幼细胞性贫血,但对维生素B12缺乏性贫血并不适用。近年应用亚叶酸钙作为结肠、直肠癌的辅助治疗,与氟尿嘧啶联合应用,可延长存活期。

用法用量

1、高剂量甲氨蝶呤治疗后亚叶酸钙“解救”疗法:根据甲氨蝶呤的血药浓度决定亚叶酸钙的剂量。一般静脉注射甲氨蝶呤24小时后,给予亚叶酸钙10mg/m2,每6时1次,共10次。如有消化道毒性反应出现时,不要鞘内注射本品。亚叶酸钙使用指导剂量:2、甲氨蝶呤消除不畅或不慎超剂量使用时:当不慎超剂量使用甲氨蝶呤时,应尽可能及时地使用亚叶酸钙进行急救;排泄延迟时,也应在甲氨喋呤使用24小时内应用亚叶酸钙。一般每6小时肌注或静脉注射亚叶酸钙10mg,直到血中甲氨蝶呤水平低于10-8M(0.01μmol)。出现消化系统反应(如恶心、呕吐)时,亚叶酸钙可胃肠外给药,但不可鞘内注射。血肌酐、甲氨喋呤水平每隔24小时测定一次,如24小时血肌酐增加超过50%或24小时甲氨蝶呤超过9×10-7M,亚叶酸钙剂量增加到100mg/m2,每3小时一次,直到甲氨蝶呤水平低于10-8M。3、叶酸缺乏引起的巨细胞性贫血:一般每天1mg,尚无根据证明剂量增加疗效会增加。4、结直肠癌:(1)5-Fu370mg/m2静注后,亚叶酸钙200mg/m2,缓慢静脉注射,不少于3分钟。(2)5-Fu425mg/m2静注后,亚叶酸钙20mg/m2,静脉注射。

不良反应

很少见,偶见皮疹、荨麻疹或引起哮喘急性发作等。

禁忌

尚不明确。

贮藏

遮光,密闭保存。

规格

300mg

证据Evidence

  • 批准文号: 国药准字H20060199
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.